Skip to main content

zilucoplan (Zilbrysq®)

 

Status: Excluded due to NICE appraisal

Product meets AWMSG exclusion criteria due to NICE appraisal ID4008: Zilucoplan for treating antibody positive generalised myasthenia gravis ID4008

Medicine details

Medicine name zilucoplan (Zilbrysq®)
Formulation Solution for injection
Reference number 4568
Indication

Treatment of generalized myasthenia gravis

Company UCB Pharma Ltd
BNF chapter Musculoskeletal & joint diseases
Assessment type N/A
Status Excluded due to NICE appraisal
Date of issue 17/03/2023
NICE guidance

ID4008: Zilucoplan for treating antibody positive generalised myasthenia gravis ID4008

Follow AWTTC: